Angiotensin receptor / neprilysin inhibitors (ARNIs) : the new hope in the management of heart failure

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 9

Abstract

Heart failure (HF) represents major challenges in cardiovascular disease and despite newer therapeutic advances, mortality still remains high. Inhibition of neurohumoural pathways such as the renin angiotensin aldosterone and sympathetic nervous systems is central in the management of heart failure. LCZ696 (sacubutril/valsartan), a first-in-class angiotensin II AT1 receptor neprilysin inhibitor (ARNI), has a unique mode of action that targets both pathways. The Prospective comparison of ARNI with angiotensin convertase enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) trial demonstrated that morbidity and mortality can be improved with the ARNI. This trial suggests that sacubitril/valsartan should replace an ACE inhibitor or angiotensin receptor blocker for the treatment of symptomatic patients (NYHA II–IV) with HF with reduced ejection fraction. This review will explore the background of neprilysin inhibition in management of HF, the results of the PARADIGM-HF trial and also guide how to use sacubitril/valsartan in clinical practice.

Authors and Affiliations

Soumya Patra, Rabin Chakraborty

Keywords

Related Articles

Evaluation of awareness and practice of pharmacovigilance among medical practitioners

The recent launch of National Pharmacovigilance program which is still in infancy. In India, problem is under-reporting of ADRs. This study was aimed at investigating the knowledge, attitude and awareness about ADR repor...

Optimal management of Hypothyroidism

Hypothyroidism was the first of the endocrine disease treated by replacement of the deficient hormone with extracts of animal thyroid glands. The development of more purified and synthetic thyroid hormone preparations ha...

Giant common bile duct stone

A forty year old female presented with pain in epigastrum, right hypochondrium and jaundice for the last one month. On examination the patient had mild pallor and icterus. Ultrasound of abdomen showed multiple stones in...

Maternal and perinatal outcome in post renal transplant patients on immunosuppressive therapy : a report of five cases

Infertility is common in patients with end stage renal disease because women do not ovulate and are unable to conceive1,2. But as renal function improves following kidney transplantation (KT), normal ovulatory cycles and...

Overview of high risk pregnancy

With the changing demographics of Indian Population including increasing maternal age and weight during pregnancy, higher rates of pregnancies conceived by artificial technology and increasing number of caesarean section...

Download PDF file
  • EP ID EP615329
  • DOI -
  • Views 142
  • Downloads 0

How To Cite

Soumya Patra, Rabin Chakraborty (2018). Angiotensin receptor / neprilysin inhibitors (ARNIs) : the new hope in the management of heart failure. Journal of the Indian Medical Association, 116(9), 42-44. https://europub.co.uk/articles/-A-615329